1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pharmaceuticals: Top 5 Emerging Markets Industry Guide

Pharmaceuticals: Top 5 Emerging Markets Industry Guide

  • January 2016
  • -
  • MarketLine
  • -
  • 140 pages

Summary

Table of Contents

Search Inside

Introduction

The Emerging 5 Pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market share, market size (value , and forecast to 2019). The guide also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Features and benefits

* Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging five pharmaceuticals market
* Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging five pharmaceuticals market
* Leading company profiles reveal details of key pharmaceuticals market players’ emerging five operations and financial performance
* Add weight to presentations and pitches by understanding the future growth prospects of the emerging five pharmaceuticals market with forecasts
* Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country

Highlights

These countries contributed $144.6 billion to the global pharmaceuticals industry in 2014, with a compound annual growth rate (CAGR) of 15.6% between 2007 and 2011. The top 5 emerging countries are expected to reach a value of $269.9 billion in 2019, with a CAGR of 13.3% over the 2014-19 period.
Within the pharmaceuticals industry, China is the leading country among the top 5 emerging nations, with market revenues of $94.4 billion in 2014. This was followed by Brazil and India with a value of $17.8 and $16.0 billion, respectively.
China is expected to lead the pharmaceuticals industry in the top five emerging nations, with a value of $191.3 billion in 2019, followed by India and Brazil with expected values of $33.4 and $24.9 billion, respectively.

Your key questions answered

* What was the size of the emerging five pharmaceuticals market by value in 2014?
* What will be the size of the emerging five pharmaceuticals market in 2019?
* What factors are affecting the strength of competition in the emerging five pharmaceuticals market?
* How has the market performed over the last five years?
* Who are the top competitors in the emerging five pharmaceuticals market?

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 Summary Systemic Lupus Erythematosus (SLE) is a systemic inflammatory autoimmune disease ...

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025 Summary Ulcerative Colitis (UC) is a type of chronic IBD that causes inflammation and ulcers in the innermost lining of ...

PharmaFocus: Tauopathies - Global Market Analysis

PharmaFocus: Tauopathies - Global Market Analysis

  • $ 9495
  • Industry report
  • February 2017
  • by GlobalData

PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.